- Home
- KLRS vs NEXM Comparison
KLRS vs NEXM Comparison
Compare KLRS & NEXM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KLRS | NEXM |
|---|---|---|
| Founded | 2019 | N/A |
| Country | United States | Canada |
| Employees | N/A | 204 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 92.8M | 82.7M |
| IPO Year | 2020 | 2002 |
Fundamental Metrics
Financial Performance| Metric | KLRS | NEXM |
|---|---|---|
| Price | $3.90 | $2.33 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $19.00 | N/A |
| AVG Volume (30 Days) | ★ 43.5K | 35.5K |
| Earning Date | 05-13-2026 | 05-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 75.70 | ★ 1044.00 |
| EPS | N/A | ★ 0.63 |
| Revenue | ★ $165,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $3.67 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.03 | $2.03 |
| 52 Week High | $11.88 | $6.65 |
Technical Indicators
Market Signals| Indicator | KLRS | NEXM |
|---|---|---|
| Relative Strength Index (RSI) | 47.07 | 48.19 |
| Support Level | $3.92 | $2.29 |
| Resistance Level | $4.37 | $2.38 |
| Average True Range (ATR) | 0.24 | 0.17 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 30.00 | 28.33 |
Price Performance
Historical ComparisonAbout KLRS Kalaris Therapeutics Inc.
Kalaris Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for prevalent retinal diseases. The company is developing TH103, a novel, clinical-stage anti-vascular endothelial growth factor VEGF drug, engineered to potentially provide longer-lasting and increased anti-VEGF activity in patients with exudative and neovascular retinal diseases. TH103 is a fully humanized recombinant fusion protein, functioning as a decoy receptor (a VEGF trap), leveraging salient molecular properties of the human body's native, highest affinity VEGF receptor 1.
About NEXM NexMetals Mining Corp.
NexMetals Mining Corp is a mineral exploration and development company focused on discovering and advancing high-quality copper-nickel-cobalt-platinum element metals (Cu- Cu-Ni-Co-PGE) resources. The group prioritizes projects in stable, mining-friendly jurisdictions with supportive foreign investment and rule-of-law standards. Its projects are Botswana and Canada.